Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guibin Lin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Oncology Letters|February 2, 2018
MLN4924 neddylation inhibitor promotes cell death in paclitaxel-resistant human lung adenocarcinoma cellsQiang Xu, Guibin Lin, Huizhe Xu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 7, 2024
Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccineGuibin Lin, Yan-Lai Tang, Zhengqiang Fu, et al.
International Journal of Biological Macromolecules|November 12, 2025
Self-amplifying mRNA nanovaccine encoding GM-CSF-fused HPV16 E7 enhances immunogenicity and therapeutic efficacy against cervical cancerGuibin Lin, Xun Guo, Zhengqiang Fu, et al.
American Journal of Cancer Research|February 18, 2016
Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagyLulu Hu, Sulan Sun, Tianpeng Wang, et al.
Cancer Letters|November 21, 2015
Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cellsZhen Li, Ke Jiang, Xiaofang Zhu, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 26, 2018
Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylationMin Liu, Ke Jiang, Guibin Lin, et al.
Oncotarget|March 31, 2016
Tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell deathKe Jiang, Min Liu, Guibin Lin, et al.
BMC Cancer|July 20, 2018
Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cellsKe Jiang, Cuiping Song, Lingkai Kong, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncology Letters|February 2, 2018
MLN4924 neddylation inhibitor promotes cell death in paclitaxel-resistant human lung adenocarcinoma cellsQiang Xu, Guibin Lin, Huizhe Xu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 7, 2024
Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccineGuibin Lin, Yan-Lai Tang, Zhengqiang Fu, et al.
International Journal of Biological Macromolecules|November 12, 2025
Self-amplifying mRNA nanovaccine encoding GM-CSF-fused HPV16 E7 enhances immunogenicity and therapeutic efficacy against cervical cancerGuibin Lin, Xun Guo, Zhengqiang Fu, et al.
American Journal of Cancer Research|February 18, 2016
Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagyLulu Hu, Sulan Sun, Tianpeng Wang, et al.
Cancer Letters|November 21, 2015
Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cellsZhen Li, Ke Jiang, Xiaofang Zhu, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 26, 2018
Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylationMin Liu, Ke Jiang, Guibin Lin, et al.
Oncotarget|March 31, 2016
Tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell deathKe Jiang, Min Liu, Guibin Lin, et al.
BMC Cancer|July 20, 2018
Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cellsKe Jiang, Cuiping Song, Lingkai Kong, et al.
Pageof 2